Lisa Delfini - 09 Aug 2021 Form 3 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role: Chief Financial Officer
Signature: /s/ Christopher Galletta, attorney-in-fact
Issuer symbol: TRVI
Transactions as of: 09 Aug 2021
Net transactions value: $0
Form type: 3
Filing time: 09 Aug 2021, 17:29:41 UTC
Next filing: 15 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney